1. Improving Flexibility and Quality of Life for Your Patients: A Must?
Axel Heidenreich 
European Urology Supplements 
Volume 8, Issue 12, Pages (December 2009)
DOI: /j.eursup
Copyright © 2009 European Association of Urology Terms and Conditions

2. Fig. 1
Rate of incident coronary heart disease, myocardial infarction, and sudden cardiac death in prostate cancer patients receiving androgen-deprivation therapy (ADT) or no treatment [12].
European Urology Supplements 2009 8, DOI: ( /j.eursup )
Copyright © 2009 European Association of Urology Terms and Conditions

3. Fig. 2
The median percent decrease from baseline in hot flush frequency and hot flush score after 4 wk of treatment with placebo or gabapentin 300, 600, or 900mg/d [19].
European Urology Supplements 2009 8, DOI: ( /j.eursup )
Copyright © 2009 European Association of Urology Terms and Conditions